Cell-cycle progression is not essential for c-Myc to block differentiation

Oncogene

Volumn 14, Issue 23, 1997, Pages 2835-2843

  Ryan, Kevin M ^a,b   Birnie, George D ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

c Myc; Cell cycle progression; DNA binding; Max; Myeloid differentiation; Ornithine decarboxylase

Indexed keywords

MYC PROTEIN; ORNITHINE DECARBOXYLASE;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOGENS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; DNA; DNA-BINDING PROTEINS; DOWN-REGULATION; HELIX-LOOP-HELIX MOTIFS; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; ORNITHINE DECARBOXYLASE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0030860849     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201124     Document Type: Article

References (49)

1. Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI and Land H. (1993a). Cell, 72, 233-245.
2. Amati B, Littlewood TD, Evan GI and Land H. (1993b). EMBO J., 12, 5083-5087.
3. Askew DS, Ashmun RA, Simmons BC and Cleveland JL. (1991). Oncogene, 6, 1915-1922.
4. Auvinen M, Paasinen A, Andersson LC and Holtta E. (1992). Nature, 360, 355-358.
5. Ayer DE and Eisenman RN. (1993). Genes Dev., 7, 2110-2119.
6. Bacon TA and Wickstrom E. (1991). Oncogene Res., 6, 21-32.
7. Beijersbergen RL, Hijmans EM, Zhu L and Bernards R. (1994). EMBO J., 13, 4080-4086.
8. Blackwood EM, Kretzner L and Eisenman RN. (1992). Curr. Opin. Genet. Dev., 2, 227-235.
9. Bowlin TL, McKnown BJ and Sunkara PS. (1986). Cell Immunol., 98, 341-350.
10. Burgess TL, Fisher EF, Ross SL, Bready JV, Qian Y-X, Bayewitch LA, Cohen AM, Herrera CJ, Hu SS-F, Kramer TB, Lott FD, Martin FH, Pierce GF, Simonet I and Farrell CL. (1995). Proc. Natl. Acad. Sci. USA, 92, 4051-4055.
11. Chavany C, Connell Y and Neckers L. (1995). Mol. Pharmacol., 48, 738-746.
12. Crouch DH, Fisher F, Clark W, Jayaraman P-S, Coding CR and Gillespie DAF. (1993). Oncogene, 8, 1849-1855.
13. Eilers M, Schrim S and Bishop JM. (1991). EMBO J., 10, 133-141.
14. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC. (1992). Cell, 69, 119-128.
15. Evan GI and Littlewood TD. (1993). Curr. Opin. Genet. Dev., 3, 44-49.
16. Field JK and Spandidos DA. (1990). Anticancer Res., 10, 1-22.
17. Finkelstein R and Weinberg R. (1988). Oncogene Res., 3, 287-292.
18. Freytag SO and Geddes TJ. (1992). Science, 256, 379-382.
19. Gu W, Bhatia K, Magrath IT, Dang CV and Dalla-Favera R. (1994). Science, 264, 251-254.
20. Hann SR, Dixit M, Sears RC and Sealy L. (1994). Genes Dev., 8, 2441-2452.
21. Harris P and Ralph P. (1985). Leukocyte Biol., 37, 407-422.
22. Hayashi S-I and Murakami Y. (1995). Biochem. J., 306, 1-10.
23. Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R and Neckers LM. (1987). Nature, 328, 445-449.
24. Hickok NJ, Wahlfors J, Crozat A, Halmekyto HM, Alhonen L, Janne J and Janne OA. (1990). Gene, 93, 257-263.
25. Holt JT, Redner RL and Nienhuis AW. (1988). Mol. Cell. Biol., 8, 963-973.
26. Hopewell R and Ziff EB. (1995). Mol. Cell. Biol., 15, 3470-3478.
27. Ingvarsson S. (1990). Semin. Cancer Biol., 1, 359-369.
28. Kelly K and Siebenlist U. (1986). Ann. Rev. Immunol., 4, 317-338.
29. Lachman HM and Skoultchi AI. (1984). Nature, 310, 592-594.
30. Land H, Parada L and Weinberg RA. (1983). Nature, 304, 596-602.
31. La Rocca SA, Crouch DH and Gillespie DAF. (1994). Oncogens, 9, 3499-3508.
32. Larsson L-G, Pettersson M, Oberg F, Nilsson K and Luscher B. (1994). Oncogene, 9, 1247-1252.
33. Li L-h, Nerlov C, Prendergast G, MacGregor D and Ziff EB. (1994). EMBO J., 13, 4070-4079.
34. Luk GD, Civin CI, Weissman RM and Baylin SB. (1982). Science, 216, 75-77.
35. Luscher B and Eisenman RN. (1990). Genes Dev., 4, 2025-2035.
36. Maruyama K, Schiavi SC, Huse W, Johnson GL and Ruley HE. (1987). Oncogene, 1, 361-367.
37. Mitchell LS, Neill RA and Birnie GD. (1992). Differentiation, 49, 119-125.
38. Packham G and Cleveland JL. (1994). Mol. Cell. Biol., 14, 5741-5747.
39. Pegg AE. (1986). Biochem. J., 234, 249-262.
40. Phillip A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K and Eilers M. (1994). Mol. Cell. Biol., 14, 4032-4043.
41. Roy AL, Carruthers C, Gutjahr T and Roeder RG. (1993). Nature, 365, 356-361.
42. Sawyers CL, Callahan W and Witte ON. (1992). Cell. 70, 901-910.
43. Shrivastava A, Saleque S, Kalpana GV, Artandi S, Goff SP and Calame K. (1993). Science, 262, 1889-1892.
44. Spencer CA and Groudine M. (1991). Adv. Cancer Res., 56, 1-48.
45. Stacey G, Bolton B, Doyle A and Griffiths B. (1992). Cytotechnology, 9, 211-216.
46. Suggs SV, Wallace RB, Hirose T, Kawashima EM and Itakura K. (1981). Proc. Natl. Acad. Sci. USA, 78, 6613-6617.
47. Wagner AJ, Meyers C, Laimins LA and Hay N. (1993). Cell Growth and Differ., 4, 879-883.
48. Wickstrom EL, Bacon TA, Gonzalez A, Freeman DL, Lyman GH and Wickstrom E. (1988). Proc. Natl. Acad. Sci. USA, 85, 1028-1032.
49. Zimmerman K and Alt FW. (1990). Crit. Rev. in Oncogenesis, 2, 75-95.